Cost-effectiveness of inactivated influenza vaccination in children with medical risk conditions in the Netherlands.
| dc.contributor.author | Naber, Steffie K | |
| dc.contributor.author | Bruijning-Verhagen, Patricia C J L | |
| dc.contributor.author | de Hoog, Marieke L A | |
| dc.contributor.author | van Giessen, Anoukh | |
| dc.date.accessioned | 2020-08-16T20:07:31Z | |
| dc.date.available | 2020-08-16T20:07:31Z | |
| dc.date.issued | 2020-04-09 | |
| dc.identifier.doi | 10.1016/j.vaccine.2020.01.057 | |
| dc.identifier.issn | 1873-2518 | |
| dc.identifier.journal | Vaccine 2020; 38(17):3387-96 | en_US |
| dc.identifier.pmid | 32115297 | |
| dc.identifier.uri | http://hdl.handle.net/10029/624144 | |
| dc.language.iso | en | en_US |
| dc.source.journaltitle | Vaccine | |
| dc.subject | Cost-effectiveness | en_US |
| dc.subject | High-risk medical condition | en_US |
| dc.subject | Influenza vaccination | en_US |
| dc.title | Cost-effectiveness of inactivated influenza vaccination in children with medical risk conditions in the Netherlands. | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: